Common Stock, Shares, Outstanding of HALOZYME THERAPEUTICS, INC. from 31 Dec 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
HALOZYME THERAPEUTICS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 31 Dec 2025.
  • HALOZYME THERAPEUTICS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 117,782,000, a 4.4% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

HALOZYME THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 117,782,000 -5,356,000 -4.4% 31 Dec 2025 10-K 17 Feb 2026 2025 FY
Q3 2025 117,523,000 -9,660,000 -7.6% 30 Sep 2025 10-Q 03 Nov 2025 2025 Q3
Q2 2025 117,621,000 -8,914,000 -7% 30 Jun 2025 10-Q 05 Aug 2025 2025 Q2
Q1 2025 123,170,000 -4,016,000 -3.2% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 123,138,000 -3,632,000 -2.9% 31 Dec 2024 10-K 17 Feb 2026 2025 FY
Q3 2024 127,183,000 -4,898,000 -3.7% 30 Sep 2024 10-Q 31 Oct 2024 2024 Q3
Q2 2024 126,535,000 -5,321,000 -4% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 127,186,000 -4,476,000 -3.4% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 126,770,000 -8,384,000 -6.2% 31 Dec 2023 10-K 18 Feb 2025 2024 FY
Q3 2023 132,081,000 -3,130,000 -2.3% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 131,856,000 -5,825,000 -4.2% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 131,662,000 -6,226,000 -4.5% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 135,154,000 -2,344,000 -1.7% 31 Dec 2022 10-K 20 Feb 2024 2023 FY
Q3 2022 135,211,000 -5,755,000 -4.1% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 137,681,000 -4,499,539 -3.2% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 137,888,000 -5,492,373 -3.8% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 137,498,000 +2,468,000 +1.8% 31 Dec 2021 10-K 21 Feb 2023 2022 FY
Q3 2021 140,966,000 +5,596,641 +4.1% 30 Sep 2021 10-Q 02 Nov 2021 2021 Q3
Q2 2021 142,180,539 +5,508,685 +4% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 143,380,373 +8,015,860 +5.9% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 135,030,000 -1,682,580 -1.2% 31 Dec 2020 10-K 22 Feb 2022 2021 FY
Q3 2020 135,369,359 -11,087,650 -7.6% 30 Sep 2020 10-Q 02 Nov 2020 2020 Q3
Q2 2020 136,671,854 -9,187,046 -6.3% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 135,364,513 -10,000,487 -6.9% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 136,712,580 -8,012,584 -5.5% 31 Dec 2019 10-K 23 Feb 2021 2020 FY
Q3 2019 146,457,009 +1,935,009 +1.3% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 145,858,900 +1,636,900 +1.1% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 145,365,000 +1,479,000 +1% 31 Mar 2019 10-Q 07 May 2019 2019 Q1
Q4 2018 144,725,164 +1,936,164 +1.4% 31 Dec 2018 10-K 24 Feb 2020 2019 FY
Q3 2018 144,522,000 +2,221,000 +1.6% 30 Sep 2018 10-Q 06 Nov 2018 2018 Q3
Q2 2018 144,222,000 +2,314,000 +1.6% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 143,886,000 +14,064,000 +11% 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 142,789,000 +13,287,000 +10% 31 Dec 2017 10-K 21 Feb 2019 2018 FY
Q3 2017 142,301,000 +12,813,000 +9.9% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 141,908,000 +12,497,000 +9.7% 30 Jun 2017 10-Q 08 Aug 2017 2017 Q2
Q1 2017 129,822,000 +708,000 +0.55% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 129,502,000 +1,350,000 +1.1% 31 Dec 2016 10-K 20 Feb 2018 2017 FY
Q3 2016 129,488,000 +1,677,000 +1.3% 30 Sep 2016 10-Q 07 Nov 2016 2016 Q3
Q2 2016 129,411,000 +1,647,000 +1.3% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 129,114,000 +1,951,000 +1.5% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 128,152,000 +2,431,000 +1.9% 31 Dec 2015 10-K 28 Feb 2017 2016 FY
Q3 2015 127,811,000 +2,265,000 +1.8% 30 Sep 2015 10-Q 09 Nov 2015 2015 Q3
Q2 2015 127,764,000 +2,470,000 +2% 30 Jun 2015 10-Q 10 Aug 2015 2015 Q2
Q1 2015 127,163,000 +2,680,000 +2.2% 31 Mar 2015 10-Q 11 May 2015 2015 Q1
Q4 2014 125,721,000 +11,187,000 +9.8% 31 Dec 2014 10-K 29 Feb 2016 2015 FY
Q3 2014 125,546,000 +11,559,261 +10% 30 Sep 2014 10-Q 10 Nov 2014 2014 Q3
Q2 2014 125,294,000 +12,008,418 +11% 30 Jun 2014 10-Q 11 Aug 2014 2014 Q2
Q1 2014 124,483,000 +11,340,100 +10% 31 Mar 2014 10-Q 12 May 2014 2014 Q1
Q4 2013 114,534,000 +1,824,826 +1.6% 31 Dec 2013 10-K 02 Mar 2015 2014 FY
Q3 2013 113,986,739 +1,294,212 +1.1% 30 Sep 2013 10-Q 08 Nov 2013 2013 Q3
Q2 2013 113,285,582 +596,985 +0.53% 30 Jun 2013 10-Q 07 Aug 2013 2013 Q2
Q1 2013 113,142,900 +731,886 +0.65% 31 Mar 2013 10-Q 08 May 2013 2013 Q1
Q4 2012 112,709,174 +8,719,902 +8.4% 31 Dec 2012 10-K 28 Feb 2014 2013 FY
Q3 2012 112,692,527 +9,044,597 +8.7% 30 Sep 2012 10-Q 08 Nov 2012 2012 Q3
Q2 2012 112,688,597 +9,079,178 +8.8% 30 Jun 2012 10-Q 09 Aug 2012 2012 Q2
Q1 2012 112,411,014 31 Mar 2012 10-Q 07 May 2012 2012 Q1
Q4 2011 103,989,272 +3,408,423 +3.4% 31 Dec 2011 10-K 01 Mar 2013 2012 FY
Q3 2011 103,647,930 30 Sep 2011 10-Q 08 Nov 2011 2011 Q3
Q2 2011 103,609,419 30 Jun 2011 10-Q 05 Aug 2011 2011 Q2
Q4 2010 100,580,849 31 Dec 2010 10-K 12 Mar 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.